Literature DB >> 11943206

Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly.

Shona M McFarlane1, Ghazaleh Pashmi, Michelle C Connell, Alison F Littlejohn, Steven J Tucker, Peter Vandenabeele, David J MacEwan.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha) signals though two receptors, TNFR1 and TNFR2. TNFR1 has a role in cytotoxicity, whereas TNFR2 regulates death responses or proliferation. TNF activates pro-inflammatory transcription factor nuclear factor-kappaB (NF-kappaB) by uncertain signalling mechanisms. Here we report the contribution of each TNFR towards the NF-kappaB activation processes. In human cells expressing endogenous or exogenous TNFR2, in addition to TNFR1, we found both TNFRs capable of activating NF-kappaB, as measured by IkappaBalpha (inhibitor of NF-kappaB) degradation, electrophoretic mobility shift assay and NF-kappaB gene reporter assays. TNFR2 activation did not degrade IkappaBbeta. However, TNF-effects on NF-kappaB activation occurred predominantly through TNFR1, with TNFR2 activating the transcription factor poorly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943206     DOI: 10.1016/s0014-5793(02)02450-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

1.  Characterisation, expression and promoter analysis of an interleukin 10 homologue in the puffer fish, Fugu rubripes.

Authors:  Jun Zou; Melody S Clark; Chris J Secombes
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

2.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.

Authors:  Alicia S Chung; Ying-Jie Guan; Zheng-Long Yuan; Jorge E Albina; Y Eugene Chin
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  SSeCKS promotes tumor necrosis factor-alpha autocrine via activating p38 and JNK pathways in Schwann cells.

Authors:  Zhengming Zhou; Tao Tao; Yuhong Ji; Huiguang Yang; Youhua Wang; Chun Cheng; Aiguo Shen; Xiang Lu
Journal:  Cell Mol Neurobiol       Date:  2010-01-29       Impact factor: 5.046

5.  The role of TNF-alpha and its receptors in the production of beta-1,4-galactosyltransferase I mRNA by rat primary type-2 astrocytes.

Authors:  Meijuan Yan; Chunlin Xia; Shuqiong Niu; Chun Cheng; Xiaoyi Shao; Aiguo Shen
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

6.  TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells.

Authors:  Yongwei Qin; Chun Cheng; Haibo Wang; Xiaoyi Shao; Yongjing Gao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-01-17       Impact factor: 3.996

7.  The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.

Authors:  Wei-Kuang Liu; Pei-Fen Yen; Chia-Yi Chien; Ming-Ji Fann; Jin-Yuan Su; Chen-Kung Chou
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

8.  Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Authors:  Ian Todd; Paul M Radford; Kelly-Ann Draper-Morgan; Richard McIntosh; Susan Bainbridge; Peter Dickinson; Lama Jamhawi; Marios Sansaridis; Mary L Huggins; Patrick J Tighe; Richard J Powell
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

9.  Nystatin interferes with the effects of N-methyl-N'-nitro-N-nitrosoguanidine on sphingolipid metabolism in human FL cells.

Authors:  Guangyi Liu; Weimin Wang; Gongping Sun; Xiaoqiong Ma; Ziyang Liu; Jun Yang
Journal:  Lipids       Date:  2008-07-15       Impact factor: 1.880

10.  Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells.

Authors:  Sharmila Masli; Bruce Turpie
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.